This fluoroscopy image shows the sensational angiography of an 86-year-old man, a former national marathon champion, affected by heart failure with reduced ejection fraction (EF 38%) and multiple comorbidities, including permanent atrial fibrillation, chronic coronary syndrome, severe aortic stenosis, and secondary mitral regurgitation. In the last decades, several percutaneous procedures were performed, such as coronary angioplasty with implantation of drug-eluting stents (DES) in the left anterior descending artery and right coronary artery (A), transcatheter aortic valve implantation (TAVI) with CoreValve™ Evolut 34 mm (B) because of severe aortic stenosis, and CRT-P Medtronic™ Percepta Quad implantation (C) because of left bundle branch block and systolic ventricular dysfunction. Furthermore, he underwent percutaneous left atrial appendage closure (LAAC) with Amplatzer™ Amulet™ 28 mm (D) due to an ischaemic stroke that occurred during anticoagulant therapy with vitamin K antagonist (VKA), and mitral transcatheter edge-to-edge repair (TEER) with implantation of two MitraClip™ G4 NTW (E) because of functional severe mitral valve regurgitation. Finally, the severe left ventricular dysfunction and the elevated number of hospitalizations despite the optimal medical therapy made it necessary to implant the CardioMEMS™ (F) in the left pulmonary artery to optimize clinical management. This has made it possible to reduce hospitalizations from 13 to 4 per year. The patient is now being evaluated for tricuspid valve intervention due to massive and clinically relevant tricuspid regurgitation.